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Abstract
The objective of this paper was to compare health outcomes and hospital care use of very
low birth weight (VLBW), and very preterm (VLGA) infants in seven European countries.
Analysis was performed on linkable patient-level registry data from seven European coun-
tries between 2006 and 2008 (Finland, Hungary, Italy (the Province of Rome), the Nether-
lands, Norway, Scotland, and Sweden). Mortality and length of stay (LoS) were adjusted for
differences in gestational age (GA), sex, intrauterine growth, Apgar score at five minutes,
parity and multiple births. The analysis included 16,087 infants. Both the 30-day and one-
year adjusted mortality rates were lowest in the Nordic countries (Finland, Sweden and Nor-
way) and Scotland and highest in Hungary and the Netherlands. For survivors, the adjusted
average LoS during the first year of life ranged from 56 days in the Netherlands and Scot-
land to 81 days in Hungary. There were large differences between European countries in
mortality rates and LoS in VLBW and VLGA infants. Substantial data linkage problems were
observed in most countries due to inadequate identification procedures at birth, which limit
data validity and should be addressed by policy makers across Europe.
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Introduction
The rate of preterm births is increasing worldwide and great disparities exist in survival rates
and quality and access to care across countries, particularly regarding very low birth weight
(VLBW) infants, less than 1500 grams at birth, and very low gestational age (VLGA) infants,
less than 32 weeks [1,2]. Although it is assumed that there are country variations in perfor-
mance and outcomes for VLBW and VLGA infants [3–5], most population-based studies have
focused on a single country [1,6], on single regions in different countries [7] or on differences
between two countries [3]. Several national [3,6,8–10] and international [11] neonatal net-
works have been established to routinely gather and analyse data on VLBW and VLGA infants
to provide comparison data for quality surveillance and factors influencing mortality and mor-
bidity. However, they commonly assess a selective sample of infants treated in neonatal inten-
sive care units (NICU) that are recognized for excellence and participating in the networks. As
a consequence, these comparative studies have a limited capacity to capture the performance
patterns of the overall organization of care for all VLBW and VLGA infants and to address
enduring disparities in treatment due to regional and national differences.
The EuroHOPE (European Health Care Outcomes, Performance and Efficiency) study uses
administrative data that has a more comprehensive perspective since it potentially includes all
neonatal care, extending the focus of interest beyond “excellent” hospital structures as well as
beyond the first hospitalization. Furthermore, the EuroHOPE study provides a multi-country
international comparison of a vulnerable and growing segment of the population. Finally, it
provides a shared methodology for standardising widely available administrative data from
various countries in such a way that allows for regular population-based monitoring in the
future as an ongoing international comparison [12], without the need for costly survey
research, center enrolment or manual consultation of hospital records.
The aim of this study is to compare mortality rates and hospital care use of VLBW and
VLGA infants in seven European countries; a second objective is to provide some insight
regarding the validity and feasibility of using an administrative database approach for this pop-
ulation, comparing incidence and outcomes measured in the EuroHOPE study to those
reported in the literature and providing some recommendations for how to improve data col-
lection, preparation and use.
Materials and Methods
Study population
The study population consisted of VLBW and VLGA infants born between 1st Jan 2006 and
31st Dec 2008 in seven European countries (Finland, Hungary, Italy (the Province of Rome),
the Netherlands, Norway, Scotland, and Sweden). Due to limited data availability, only infants
born between 2008 and 2009 in Norway, and between 2006 and 2007 in the Netherlands, were
analysed. Italian data is decentralized, managed autonomously by the different regions. Due to
privacy regulations and the quality of the regional Medical birth registries (MBR), of three
potential areas surveyed for data suitability, only the Province of Rome provided a sufficiently
high data linkage rate with the MBR for the study. Infants were followed for up to 365 days
after the day of birth; stillborn infants were not included in the study population. The live-born
infants selected for cohorts complied with at least one of the two criteria for inclusion: weight
at birth less than or equal to 1500 grams and gestational age (GA) less than 32 weeks. In other
words, all infants below or equal to 1500 g and all infants below 32 weeks were included.
Infants with incorrect identification numbers (ID) were excluded as this precluded linkage
between records from Medical birth registry and other information registries. Infants with the
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following lethal congenital malformations were also excluded (ICD-9 and ICD-10 codes,
respectively, are listed after each): anencephaly (740.0, Q00.0), transposition of great vessels
(745.15, Q20.1), hypoplastic left heart syndrome (746.7, Q23.4), renal agenesis and dysgenesis
(753.0, Q60.2), anomalies of diaphragm (756.6, Q79.0, Q79.1), Patau's syndrome (758.1,
Q91.7), and Edward's syndrome (758.2, Q91.3).
Infants born before 22 weeks of GA and after 39 weeks of GA were excluded, as were infants
with major disparities between GA and weight. Major disparities between GA and weight were
defined to exclude likely transcription errors in the registries—a detailed description of the
methods appears in the Discussion Paper, available at www.eurohope.info. Finally, in each
country the infants with a length of stay (LoS) for all initial (continuous) hospital treatment
longer than the 99th percentile in that country were excluded. Presumably a very long LoS
could reflect errors in data or very severely ill infants not captured properly with our exclusion
criteria which could compromise comparison of countries.
In each country, the MBR was used as the primary source of information, and subsequently
linked with the hospital discharge register (HDR) and the Causes-of-Death registries. A Causes
of Death registry does not exist in Hungary; however, the social security ID registry records
deaths without reporting the ICD code for the cause. The registries were linked at the individ-
ual patient level using national personal ID, except in Hungary and the Netherlands, where
deterministic and stochastic linkage were employed since the MBR and/or HDR does not
include an ID for the newborn. Infants in other countries with a missing or incomplete ID in
the MBR were excluded from the study. In Sweden and Norway, information on mortality was
linkable with information on birth; however, difficulty linking the MBR to the HDR meant that
follow-up treatment through one year was available for only 58% and 65%, respectively, of
infants. This limitation was nationwide and not related to some specific regions; analysis
revealed that there was a bias toward the exclusion of infants with a poorer prognosis that
would have downwardly skewed mortality rates. In order to increase the comparability of the
data, the larger population of VLBW and VLGA infants identified from birth records in Swe-
den and Norway was used to calculate mortality figs, even though the information on their
treatment during the first year of follow-up was incomplete. Consequently, however, the figs
for the LoS for both of these countries cannot be considered representative. They are presented
but refer to the restricted samples of infants for whom linkable information about follow up
treatment was available. In Scotland a similar problem is believed to have occurred where the
medical birth record for between 10 to 15% of infants meeting the criteria could not be linked
to mortality and hospital information. It is hypothesized that these infants, like in Sweden and
Norway, had a poorer prognosis and that this has led to a bias towards a relatively healthier
cohort for this study in relation to published reports [13]. In Italy and Hungary problems with
linkage were related to the delayed assignment of ID for newborns. In the Netherlands, prob-
lems included data availability only for an earlier study period (2005–2007) in a time of
improving mortality rates, a low linkage rate (estimated to be about 72%) and the dispropor-
tionate exclusion of multiple births, particularly same-sex multiple births, because of ID num-
ber difficulties, all of which likely affected mortality outcomes. In addition, national guidelines
at the time recommended active treatment only for infants> = 25 weeks GA and abortion is
legal up to 24 weeks GA, which are both assumed to have worsened mortality rates for infants
<25 weeks GA.
For each infant, the first hospital episode (FHE) was defined to include all continuous hospi-
tal stays, including transfers, from the day of birth (index day) to the day of discharge to home
from the last continuous hospital stay, or death. Subsequent episodes of hospital care were
used to calculate the total number of days spend in hospital in the first year of life.
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Ethics
This study was approved by the commissioner of the research, the European Commission. The
use of data was also approved by the data providers as follows: National Institute for Health
andWelfare (Helsinki, Finland), the National Institute for Quality- and Organizational Devel-
opment in Healthcare and Medicines (Hungary) and the Health Insurance Fund Administra-
tion (Hungary), Department of Epidemiology of the Regional Health Service—Lazio (Italy),
the Statistics Netherlands and the Netherlands Perinatal Registry (the Netherlands), the Medi-
cal Birth Registry of Norway, Statistics Norway (Norway), the Information Services Division of
National Services Scotland, NHS (Scotland), and the Swedish National Board of Health and
Welfare (Sweden). The analysis was performed on anonymized and de-identified data. The
conditions restricting the use of the data are presented in S1 Table.
Statistical analysis
To enhance the comparability of the outcome measures, the outcomes were adjusted for GA (cat-
egorized;<25 weeks, 25–26 weeks, 27–28 weeks, 29–30 weeks, 31–32 weeks,>32 weeks), sex,
intrauterine growth (defined in reference to Fenton’s [14] standardized international values),
Apgar score at five minutes, parity and multiple births. A risk adjustment approach of dividing
the observed number of outcomes by the expected number was applied (see e.g. Ash et al. [15]).
These ratios were then multiplied by the average of the outcome measure in the pooled data of
Finland, Hungary and Italy to get the risk adjusted mortality percentage or the risk adjusted LoS.
In our study, the number of expected outcomes was based on modelling with logistic regression
for mortality, and with negative binomial regression for LoS. [16] First, the regression models
were estimated using pooled individual-level data from Finland, Hungary and Italy to get coeffi-
cients for the risk adjustment factors, separately for each outcome. Then, to acquire the expected
number of outcomes in a country, each partner applied in their national data the estimated
pooled coefficients for the factors included in the risk adjustment (using Stata version 12).
Results
In the seven countries, 16,087 VLBW and VLGA newborn infants were included in the Euro-
HOPE dataset; after exclusions 15,373 (95.6%) remained and were used for the mortality analy-
sis. For the LoS analysis, an additional 436 infants in Norway and 1,325 infants in Sweden were
excluded because it was not possible to link the HDR to the MBR to measure follow-up, as
described above. The proportion of VLBW and VLGA infants over all live-born infants in the
EuroHOPE datasets varied between 0.76% in the Netherlands and 1.21% in Hungary, and are
presented in Table 1, along with the comparison to surveillance data [17].
The baseline characteristics of the infants, their mothers and information on delivery are
shown in Table 2. A supporting table (S2 Table) also shows the differences in the two datasets
for Norway and Sweden, one for mortality (all) and one for follow-up care for measuring LoS
(linkable). For Scotland, two columns also illustrate the two sets of data: the information from
the MBR (all) and the (linkable) dataset (MBR records linked to information on mortality and
hospital discharges) covering approx. 85% of all infants listed in the MBR and believed to rep-
resent a relatively healthier population. Distribution of infants across GA and birthweight
groups is presented in a supporting table (S3 Table).
The mean values of birth weight and GA are very similar across the countries, except in the
Netherlands, where the lowest GA and weight classes represent much lower proportions (1.7%
for<25 weeks GA and 0.4% for<1500 g birthweight) in comparison to other countries (rang-
ing from 3.9 to 8.7% for<25 weeks GA and 0.9 to 3.1% for<1500 g birthweight). The Italian
data show the highest mean age of mothers at delivery (33.2 years), with more than two out of
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five mothers older than 34 years. The Dutch population has a low proportion of multiple
births, 9.9%, compared to 25.4% to 33.5% in the other countries—and infants delivered by cae-
sarean section, 35.3%, in comparison to 66.3% to 77.8% for the other countries.
Crude mortality at 30 days and one year are further presented by GA in Tables 3 and 4,
showing as expected that a GA at birth of 26 weeks or earlier is related to a significantly higher
risk of mortality compared to infants born after the 26th week of GA.
However, it is interesting to note the apparent positive performance delta for Scotland and
the Nordic countries (Finland, Sweden and Norway) in crude 30-day and one year mortality
rates, especially for infants born before the 27th week of GA, as compared to Italy, Netherlands
and Hungary: proportions are on average between 10 and 20 percentage points lower for<25
weeks GA and 25–26 weeks GA. The adjusted mortality rate for all VLBW and VLGA infants
Table 1. Number and proportion of VLBW and VLGA infants among live-born infants in EuroHOPE data.
Finland Hungary Italy Netherlandsa Norwaya Scotland Sweden
Total number of VLBW and VLGA infants born in 2006–2008 1584 3702 1382 4096 1428 2451 3229
VLBW and VLGA infants after exclusions 1455 3562 1265 2628 1311 2015 3137
Linkage rate (%): possibility to link the MBR with the HDR 99% 76% 87% 65% 100%c 85% 100%d
EuroHOPE proportion, %, of VLBW and VLGA infants among live-born
infants (proportion for length of stay analysis)
0.82 1.21 1.04 0.76 1.22 1.16 0.97
Euro-Peristat 2008 [17],b incidence, %, <1500g 0.8 1.4 0.8 1.0 0.9 1.1 0.7
Euro-Peristat 2008 [17],b incidence, %, <32 weeks GA 0.9 1.4 1.0 1.1 1.0 1.2 0.9
aThe Netherlands: 2006–2007, Norway: 2008–2009
bThe European Perinatal Health Report 2008 is based on data from 2004, incidence figs are per 100 live-born infants
cThe linkage is between MBR and Cause of Death Registry. The linkage with the HDR for LoS analysis was 65%
dThe linkage is between MBR and Cause of Death Registry. The linkage with the HDR for LoS analysis was 58%
doi:10.1371/journal.pone.0131685.t001
Table 2. Characteristics of VLBW and VLGA infants andmothers and overall unadjustedmortality in the EuroHOPE datasets in seven European
countries.
Finland Hungary Italy Netherlands Norway Scotland Sweden
Number of VLBW and VLGA infants born in 2006–2008a 1584 3702 1380 4096 1428 2451 3229
Number of VLBW and VLGA infants, after exclusions 1455 3562 1265 2628 1311 2330 3137
Mean (SD) gestational age, in weeks 28.9 (2.8) 29.1 (3.0) 29.5 (2.8) 29.7 (2.5) 29.0 (2.7) 29.3 (2.8) 28.8 (2.7)
Birth weight, in grams, mean (SD) 1215 (392) 1209 (400) 1243 (407) 1277 (362) 1227 (391) 1254 (372) 1247 (414)
Female gender (%) 45.3 49.1 46.2 44.9 45.2 46.4 44.5
Apgar score at five minutes, median 8 8 7 9 8 9 8
Appropriate for gestational age (%) 78.2 71.5 67.7 72.6 77.9 76.4 80.3
Small for gestational age (%) 4.8 5.9 6.7 4.8 5.3 6.0 6.0
Multiple birth (%) 33.5 29.1 32.9 14.2 27.2 26.7 27.8
First delivery (%) 52.4 51.5 66.7 62.0 53.8 58.3 83.5
Ceasarean delivery (%) 67.3 70.2 77.8 53.6 64.5 57.4 66.3
Malformations, number (%) 45 (3.1) 9 (0.3) 196 (15.5) 21 (0.8) 117 (2.9) 182 (5.8)
Mother’s characteristics, age in years (SD) 30.7 (5.9) 30.0 (5.7) 33.2 (5.9) 30.1 (5.2) 30.8 (5.8) 28.8 (6.6) 31.2 (5.6)
Mothers over 34 years (%) 79.4 19.6 42.4 20.6 27.4 22.5 26.1
Unadjusted 30 day mortality (%) 11.4 15.7 12.7 11.5 9.7 NA 8.0
Unadjusted 1 year mortality (%) 12.9 18.1 13.8 13.1 11.2 NA 9.4
a 2008–2009 for Norway, 2005–2007 for Netherlands.
doi:10.1371/journal.pone.0131685.t002
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after one year of follow-up was 9.5% in Scotland, 10.6% in Sweden, 11.7% in Finland, and
12.1% in Norway. Higher rates were observed in Italy (14.2%) and mainly in Hungary (19.9%)
and the Netherlands (22.7%) (Fig 1).
Differences among countries were observed in the average LoS, adjusted for GA, sex, intra-
uterine growth, Apgar score at five minutes, parity and multiple births. As shown in both the
Tables 5 and 6, these differences can be observed among both infants who survived and those
who had died by the end of their first year of life. The unadjusted mean LoS for the FHE and
for the first year of follow-up by GA for survivors and non-survivors are provided separately as
supporting information documents (S1 and S2 Figs).
In survivors, the longest adjusted mean LoS during the first year of life were observed in
Hungary (81.3 days) and Finland (75.2 days). The shortest adjusted average LoS during the
first year among survivors was in the Netherlands (58.1 days) and Scotland (56.8 days). Non-
survivors spent more time in hospital in Scotland (26.2 days) and Finland (23.8 days) compared
to other countries. The shortest adjusted mean LoS for deceased infants during the first year was
observed in the Netherlands (11.5 days), Hungary (13.1 days) and Italy (13.4 days). As described
above, the figs for Sweden, Norway and Scotland for length of stay were measured with datasets
which likely represent a healthier cohort and should therefore be interpreted with caution.
Discussion
The incidence figs observed for VLBW and VLGA infants in the EuroHOPE study were consis-
tent with previous literature [1, 13, 17–26] for most countries, suggesting the feasibility of
Table 3. Unadjustedmortality rates (%) within 30 days: by gestational age.
Gestational Age Finland Hungary Italy Netherlands Norway Scotlandb Sweden
< 25 weeks 62.7 73.9 75.0 83.3 59.6 52.6 43.8
25–26 weeks 22.0 34.2 36.7 36.3 13.6 13.1 14.4
27–28 weeks 11.4 13.7 13.0 13.3 7.0 4.1 6.7
29–30 weeks 3.3 5.7 5.4 8.0 4.2 1.8 2.5
31–32 weeks 1.0 3.1 3,0 3.5 1.6 0.5 1.8
> 32 weeks 0.0 6.1 2.1 NAa 6.4 0.5 3.4
N 1455 3562 1265 2628 1311 2015 3137
a For the >32 weeks category, figs for the Netherlands were too small to be reported for two of the gestational age groupings.
b Only linkable infants included.
doi:10.1371/journal.pone.0131685.t003
Table 4. Unadjustedmortality rates (%) within 365 days: by gestational age.
Gestational Age Finland Hungary Italy Netherlands Norway Scotlandb Sweden
< 25 weeks 65.9 77.7 77.8 85.4 63.3 59.0 48.8
25–26 weeks 24.9 40.0 42.2 40.3 17.4 18.8 17.2
27–28 weeks 13.9 16.0 13.5 16.2 8.2 6.2 7.6
29–30 weeks 3.5 8.0 5.6 9.2 5.2 1.4 3.3
31–32 weeks 1.8 3.9 3.6 4.1 2.2 1.4 2.5
> 32 weeks 2.1 7.7 2.8 NAa 7.7 1.6 4.1
N 1455 3562 1265 2628 1311 2015 3137
a For the >32 weeks category, figs for the Netherlands were too small to be reported for two of the gestational age groupings.
b Only linkable infants included.
doi:10.1371/journal.pone.0131685.t004
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linking population-wide register data among European countries and the reliability of results
on incidence. Small differences between earlier studies and this study might be explained by
different inclusion and exclusion criteria, by relatively low linkage rates in some countries, by
differing observational periods, geographical areas and, particularly by the selective sampling
in some of the previous studies focused exclusively on NICUs. A low linkage rate may explain
the lower proportion of Hungarian infants enrolled in this study (1.21%), notwithstanding the
broader definition in EuroHOPE compared to the Central Statistical Office [19] data (1.48%),
which focused only on VLBW infants. The slight difference in the previous Finnish study
(0.9% vs. 0.82% here) [18] and Norwegian data (1.04% vs. 1.22% here) might stem from the
different definitions for lethal malformations we employed for data comparability and standar-
disation across countries. The incidence found in the nationwide EXPRESS study in Sweden
[1] of extremely preterm (below 27 weeks GA), live-born infants was 0.23% for the period
2004–2007, which compares to 0.20% incidence found in EuroHOPE data. To our knowledge
there have been no comparable data studies on incidence for the Netherlands and Scotland;
Fig 1. Risk adjustedmortality rates at 30 days and at 1 year. aAdjusted for gestational age (GA), sex,
intrauterine growth (small for gestational age), Apgar score at five minutes, parity and multiple births. A
confidence interval: 95%.
doi:10.1371/journal.pone.0131685.g001
Table 5. Risk adjusted average number of hospital days during FHE.a
Survivors Non-survivors
Finland 60.5 (59.2–61.8) 14.3 (8.6–20.1)
Hungary 55.6 (54.8–56.4) 11.5 (9.7–13.2)
Italy 46.2 (44.5–47.8) 12.8 (9.5–16.1)
Netherlands 53.4 (52.5–54.2) 8.7 (7.3–10.2)
Norway 53.3 (52.1–54.4) 13.2 (7.7–18.7)
Scotland 50.7 (49.6–51.8) 19.9 (14.6–25.3)
Sweden 61.0 (60.0–62.0) 15.9 (9.5–22.4)
A confidence interval: 95%.
a The first hospital episode (FHE) starts at the day of birth and includes all continuous hospital days,
including transfers between different hospitals.
doi:10.1371/journal.pone.0131685.t005
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however, surveillance data was comparable for Scotland but was considerably higher than the
proportions in the EuroHOPE database for the Netherlands (Table 1).
Our study suggests better performance of Nordic countries compared to Hungary, Italy and
the Netherlands, as reported in other studies [18, 19, 24]. We report a higher crude 1-year mor-
tality rate in the Netherlands (13.1%) compared to an earlier study (10.9%) on infants born
between 2002 and 2006 in a single high-level regional hospital with NICU capabilities, exclud-
ing infants born before 25 weeks GA [25]. Further explanation for high mortality in the Neth-
erlands in EuroHOPE data may stem from customs and policies common to the country: for
instance, the 2007 study describes national guidelines regarding care recommendations for
extremely premature infants in which active care is advised only for infants> = 25 weeks GA
and palliative care for those< 25 weeks GA. Moreover, higher mortality of Dutch infants can
be related to data linkage problems and to risk adjustment procedure; the crude mortality rates
are more comparable to other countries than the adjusted ones. As explained in the “Statistical
analysis” section, the model for risk adjustment was based only on data from Finland, Hungary
and Italy because the restriction for data use did not allow to pool data for risk adjustment
modelling from all the seven countries. It should be noted that the Dutch Health Care Perfor-
mance Report 2014 [27] confirmed consistently higher fetal and neonatal mortality rates in the
Netherlands between 2004 and 2010 in comparison to other Western European nations (12th
out of 13 for neonatal mortality), though rates have been decreasing. Compared to other Euro-
pean nations, high percentages (almost 30% in 2012) of children are born outside of a hospital
maternity unit, many at home (15.9% in 2012), in outpatient departments supervised primarily
by midwives (12.5% in 2012) or in a birth center (1.5% in 2012) [28].
Regarding the differences with previous Italian data, the adjusted one-year mortality rate in
several regions of Central Italy amounted to 19.3% [20], compared to 14.2% in EuroHOPE.
However, the EuroHOPE study refers only to the prevalently urban Province of Rome, com-
pared with the four regions of Central Italy in the previous study in 2001 of live births of infants
below 1500 g and not necessarily all those born before 32 weeks. Finally, the previous study
measured only in-hospital mortality and only infants hospitalized in NICUs.
According to the Swedish MBR 2011 report, the number of children born before GA 33rd
week amounted to 3979 during the period 2006–2008, compared with 3229 VLBW and VLGA
infants (before exclusions) in the EuroHOPE study that, however, did not include infant of 32
GA. Their neonatal (within 28 days) mortality amounted to 7.1% of live births, compared to
8.0% here. [24] Of live-born infants in the EXPRESS study of very preterm infants (below 27
weeks GA), the crude mortality rate at 28 days was 26%, compared to 26.2% at 30 days in
EuroHOPE.
Table 6. Risk adjusted average number of hospital days during the first year of life.a
Survivors Non-survivors
Finland 75.2 (73.6–76.8) 23.8 (14.1–33.5)
Hungary 81.3 (80.1–82.6) 13.1 (11.1–15.1)
Italy 71.1 (67.6–74.5) 13.4 (10.0–16.8)
Netherlands 58.1 (57.1–59.1) 9.9 (8.3–11.6)
Norway 62.9 (61.4–64.4) 18.4 (10.3–26.6)
Scotland 56.8 (55.2–58.4) 26.2 (19.0–33.4)
Sweden 65.5 (64.4–66.6) 18.7 (10.8–26.5)
A confidence interval: 95%.
a Figs include all hospital days, not necessarily continuous.
doi:10.1371/journal.pone.0131685.t006
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The Scottish Perinatal Infant Mortality and Morbidity Report [13] reports the mortality rate
within four weeks for normally-formed singleton neonates born at<1500 g as 12.5% for 2006,
17.5% for 2007, and 10.9% for 2008, excluding multiple births, which are reported separately
and without weight or GA classifications as were used for EuroHOPE analyses. In EuroHOPE
data multiple births represent 26% of the cases for Scotland. The 30-day mortality rate calcu-
lated in our data was significantly lower: only 4.7% for crude mortality and 7.3% for adjusted
mortality.
The individual characteristics of the missing cases in the Scottish EuroHOPE dataset such
as Apgar scores, GA and birthweight compare unfavourably with the rest of the study popula-
tion and suggest that the infants that are missing from the linkable database have a poorer
prognosis. As a consequence mortality among Scottish infants is very likely under-estimated in
this paper and data linkage must be improved before appropriate comparisons can be made
with other countries’ data.
Comparing the mortality figs with previous studies, it is likely that the EuroHOPE results
provide a relevant estimate of the existing situation. Further research should enhance a more
detailed understanding of mortality differences within and across countries. Among possible
explanations are the centralization of care, capacity to guarantee necessary transfers between
different levels of care, the quality of the prenatal care and a capacity to reduce risks related to
prematurity. Furthermore, the differences can be also explained by underlying socio-economic
factors such as per capita GDP, unemployment rates, poverty and population density. Last but
not least, poorer outcomes can be associated with cultural patterns that may affect risky mater-
nal behaviour, such as smoking or alcohol consumption.
As discussed at length above, there were several limitations to our study. Problems included
ID attribution at birth which precluded linkage of MBR with other registers, in particular in
Norway and Sweden, a problem described elsewhere [29], and in Scotland and the Netherlands.
The comparability of results for the Swedish and Norwegian population in terms of LoS, and
the Netherlands and Scotland for mortality is therefore limited. Furthermore, the MBR registry
is not complete in Hungary and does not always include all live-born infants, though it reached
98.4% by 2008 [19]. Although the possibility to link registries in the Province of Rome
increased to 95.1% by 2008 (Department of Epidemiology of the Regional Health Service—
Lazio, email correspondence 21 March 2011), first hospital admissions of approximately 10%
of infants transferred soon after birth were not tracked due to a late incomplete ID assignation,
which reduced FHE, and consequently LoS, figs for Italy. However, it had no impact on mortal-
ity rates. In addition, the need for standardisation for the comparative objectives did not allow
us to develop more sophisticated techniques for risk adjustments that could take into account a
broader range of confounding factors. Differences in data collection across countries made it
impossible to adjust the data for the socio-economic status of the family. Another limitation is
the exclusion of stillborn infants. There might be differences among countries in defining a
live-born infant [30] as suggested by the exceptionally low number of live-born infants below
25 weeks in the Netherlands.
Conclusions
The EuroHOPE population-based study covering a large geographical area of Europe suggests
that there are marked variations in mortality and average LoS between countries. In compari-
son to previous research, this study is not limited to a selective sample of hospitals with neona-
tal intensive care units but takes into consideration all hospitals in different countries and
therefore the overall organization of care. Days spent in hospital care for either survivors or
non-survivors were not sufficient to explain the differences in mortality between countries.
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Further studies are required to determine the relationship between organization of care, treat-
ment and outcomes. European policy makers need to ensure that reliable data are available to
provide information regarding which models of care and therapeutic strategies lead to
improved results and cost effective resource utilization. The EuroHOPE study can be used to
facilitate data gathering and standardization across countries to design methods for regular
monitoring and guide efforts to improve quality and access. Policy makers should implement
processes and guidelines ensuring the attribution of unique ID numbers immediately upon
birth to all live-born infants to facilitate a linkage of different administrative registers, within
the confines of privacy-related national legislation. Furthermore, a possibility to share confi-
dentially anonymised data at the international level would allow for more robust risk adjust-
ment models.
Supporting Information
S1 Fig. Unadjusted mean number of hospital days for FHEa and first year of follow-upb:
Survivorsc. a The first hospital episode (FHE) starts the day of birth and includes all continu-
ous inpatient hospital days, including transfers between hospitals, until discharge to home. b
All hospital days during the first year, not necessarily continuous. c Infants born 2006–2008,
2006–2007 for the Netherlands, 2008–2009 for Norway. Note: too few cases precluded report-
ing values for infants<25 weeks GA in the Netherlands. d It is believed that the problematic
linkage of follow-up admissions in 10% of Italian infants caused that the LoS figs in two groups
of infants with the lowest GA (<25 weeks, 25–26 weeks) do not represent the real picture.
(TIFF)
S2 Fig. Unadjusted mean number of hospital days for FHE a and first year of follow-upb:
Non-survivorsc. a The first hospital episode starts at the day of birth and includes all continu-
ous hospital days, including transfers between different hospitals until discharge to home. b
Figs include all hospital days during the first year, not necessarily continuous. c Infants born
2006–2008, 2006–2007 for the Netherlands, 2008–2009 for Norway.
(TIFF)
S1 Table. Administrative data sources and conditions restricting the use of data.
(DOCX)
S2 Table. Characteristics of VLBW and VLGA infants and mothers and unadjusted mortal-
ity. Linkable infants for LoS calculation included only. a 2008–2009 for Norway
(DOCX)
S3 Table. Distribution of VLBW and VLGA infants according to GA and weight at birth. a
Numbers of infants are slightly lower for birth weight classes with respect to gestational age
classes due to missing data on weight for some infants
(DOCX)
Acknowledgments
Thank you to Harry Campbell, Anne Douglas and Sarah Wild from the Centre for Population
Health Sciences University of Edinburgh for their review of the manuscript. Thank you to
Chiara Sorge from the Department of Epidemiology of the Regional Health Service—Lazio for
providing us with the data for Italy. We thank György Csákány for providing us with clinical
insight for Hungarian data collection and interpretation. We thank Chantal Hukkelhoven
from The Netherlands Perinatal Registry for reviewing the manuscript. We also acknowledge
The Netherlands Perinatal Registry and Statistics Netherlands for providing the necessary data.
VLBW and VLGA Infants in Seven European Countries
PLOS ONE | DOI:10.1371/journal.pone.0131685 June 29, 2015 10 / 12
We thank Orvar Finnström for clinical advice regarding Swedish data. Thank you to the fol-
lowing members of EuroHOPE Study Group for their feedback during different stages of the
research project: Éva Belicza, Peter Engelfriet, Fanny Goude, Terje Hagen, Tor Iversen, Sverre
A.C. Kittelsen, Roosa Kohvakka, Emma Medin, Tron Anders Moger, Alison McCallum, Clas
Rehnberg, Erika Takács, and Linda Williams. We thank two anonymous reviewers for their
valuable and constructive comments.
Author Contributions
Conceived and designed the experiments: DN GF FT RZMP PM LL SS RH FL UH TTS. Ana-
lyzed the data: DN GFMP FT HB PM SS RH STK EF AvdH EO. Wrote the paper: DN GF FT
RZ HB. Coordinated and supervised data collection: DN GF MP HB. Interpreted data: DN GF
FT RZMP HB PM LL SS RH STK EF AvdH FL EO UH TTS. Critically reviewed and revised
the manuscript: MP PM LL SS RH STK EF AvdH FL EO UH TTS.
References
1. Fellman V, Hellström-Westas L, Norman M,Westgren M, Källén K, Lagercrantz H, et al. One-year sur-
vival of extremely preterm infants after active perinatal care in Sweden. JAMA. 2009; 301: 2225–2233.
doi: 10.1001/jama.2009.771 PMID: 19491184
2. WHO. Preterm Birth. Fact sheet N°363. 2013. Available: http://www.who.int/mediacentre/factsheets/
fs363/en/. Accessed June 28 2014.
3. Isayama T, Lee SK, Mori R, Kusuda S, Fujimura M, Ye XY, et al. Comparison of mortality and morbidity
of very low birth weight infants between Canada and Japan. Pediatrics. 2012; 130: e957–65. doi: 10.
1542/peds.2012-0336 PMID: 22966031
4. Van Reempts P, Gortner L, Milligan D, Cuttini M, Petrou S, Agostino R, et al. Characteristics of neonatal
units that care for very preterm infants in Europe: results from the MOSAIC study. Pediatrics. 2007;
120: e815–e825. PMID: 17908739
5. Zeitlin J, Szamotulska K, Drewniak N, Mohangoo AD, Chalmers J, Sakkeus D, et al. Preterm birth time
trends in Europe: A study of 19 countries. BJOG An Int J Obstet Gynaecol. 2013; 120: 1356–1365.
6. Kugelman A, Reichman B, Chistyakov I, Boyko V, Levitski O, Lerner-Geva L, et al. Postdischarge Infant
Mortality Among Very Low Birth Weight Infants: A Population-Based Study. Pediatrics. 2007; 120:
e788–e794. PMID: 17908737
7. Draper ES, Zeitlin J, Fenton AC, Weber T, Gerrits J, Martens G, et al. Investigating the variations in sur-
vival rates for very preterm infants in 10 European regions: the MOSAIC birth cohort. Arch Dis Child
Fetal Neonatal Ed. 2009; 94: F158–F163. doi: 10.1136/adc.2008.141531 PMID: 18805823
8. Kusuda S, Fujimura M, Uchiyama A, Totsu S, Matsunami K. Trends in morbidity and mortality among
very-low-birth-weight infants from 2003 to 2008 in Japan. Pediatr Res. 2012; 72: 531–538 doi: 10.1038/
pr.2012.114 PMID: 22922774
9. Gagliardi L, Tagliabue P, Bellù R, Corchia C, Mosca F, Zanini R. Survey of neonatal respiratory support
use in very preterm infants in Italy. J Matern Fetal Neonatal Med. 2012;Suppl 3:1–5.
10. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, et al. Trends in neonatal morbid-
ity and mortality for very low birthweight infants. Am J Obs Gynecol. 2007; 196: 147.e1–147.e8.
11. Horbar JD, Carpenter JH, Badger GJ, Kenny MJ, Soll RF, Morrow KA, et al. Mortality and Neonatal
Morbidity Among Infants 501 to 1500 Grams From 2000 to 2009. Pediatrics. 2012; 129: 1019–1026.
doi: 10.1542/peds.2011-3028 PMID: 22614775
12. Häkkinen U, Iversen T, Peltola M, Seppälä TT, Malmivaara A, Belicza E, et al. Health care performance
comparison using a disease-based approach: The EuroHOPE project. Health Policy. 2013; 112: 100–
109. doi: 10.1016/j.healthpol.2013.04.013 PMID: 23680074
13. Information Services Division NSS. Scottish perinatal and infant mortality and morbidity report; 2009.
Available: http://www.isdscotlandarchive.scot.nhs.uk/isd/3112.html. Accessed June 26 2014.
14. Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for pre-
term infants. BMC Pediatr. 2013; 13: 59. doi: 10.1186/1471-2431-13-59 PMID: 23601190
15. Ash AS, Schwartz M, Peköz E. Comparing outcomes across providers. In: LI I, ed. Risk Adjustment for
measuring health care outcomes. Chicago: Health Administration Press; 2003: 297–333.
VLBW and VLGA Infants in Seven European Countries
PLOS ONE | DOI:10.1371/journal.pone.0131685 June 29, 2015 11 / 12
16. Moger T, Peltola M. Risk adjustment of health-care performance measures in a multinational register-
based study: A pragmatic approach to a complicated topic. SAGEOpen Med. 2014; 2. Available: http://
smo.sagepub.com/content/2/2050312114526589.full. Accessed August 27 2014.
17. EURO-PERISTAT. European Perinatal Health Report. 2008. Available: http://www.europeristat.com/
images/doc/EPHR/european-perinatal-health-report.pdf. Accessed July 14 2014.
18. Lehtonen LL, Rautava L, Korvenranta E, Korvenranta H, Peltola M, Häkkinen U. PERFECT preterm
infant study. Ann Med. 2011;Suppl 1: S47–S53.
19. Central Statistical Office. Csecsemőhalandóság Magyarországon [Infant mortality in Hungary]. Statisz-
tikai tükör. V.évfolyam. 70.szám.; 2011.
20. Corchia C, Orzalesi M. Geographic variations in outcome of very low birth weight infants in Italy. Acta
Pædiatrica. 2006; 96: 35–38.
21. The Netherlands Perinatal Registry. Perinatal care in the Netherlands, 2007. 2007. Available: http://
www.perinatreg.nl/uploads/150/116/Jaarboek_Perinatale_Zorg_2007.pdf. Accessed July 14 2014.
22. The Norvegian Perinatal Registry. Table: F5/I7. Infants by birthweight, living area of mother and birth
place type. http://mfr-nesstar.uib.no/mfr/. 2013. Available: http://mfr-nesstar.uib.no/mfr/. Accessed
October 17 2013.
23. Strand KM, Heimstad R, Iversen A, Austgulen R, Lydersen S, Andersen GL, et al. Mediators of the
association between pre-eclampsia and cerebral palsy: population based cohort study. BMJ. 2013;
4089: 1–10.
24. Swedish National Board of Health andWelfare. Graviditeter, förlossningar och nyfödda barn. Medi-
cinska födelseregistret 1973–2009. [Pregnancies, Deliveries and Newborn Infants. The Swedish Medi-
cal Birth Register 1973–2009]; 2011. Available: http://www.socialstyrelsen.se/publikationer2011/2011-
3-19/Documents/Bilaga1.pdf. Accessed August 27, 2013
25. Groenendaal F, Termote J, Van Der Heide-Jalving M, Van Haastert I, De Vries L. Complications affect-
ing preterm neonates from 1991 to 2006: What have we gained? Acta Paediatr Int J Paediatr. 2010; 99:
354–358.
26. Nordermoen A, Bratlid D. Costs for treatment of very-low-birth-weight infants. Tidsskr Nor Laegeforen.
2010; 130: 1130–34. doi: 10.4045/tidsskr.09.0378 PMID: 20531498
27. National Institute for Public Health and the Environment (RIVM), Dutch Health Care Performance
Report 2014. 2015. Available: http://www.rivm.nl/dsresource?objectid = rivmp:277134&type =
org&disposition = inline&ns_nc=1. Accessed May 12 2015.
28. Evers ACC, Brouwers HAA, Hukkelhoven PM, Nikkels PGJ, Boon J, van Egmon-Linden A, et al. Peri-
natal Mortality and Severe Morbidity in Low and High Risk Study. BMJ. 2010; 341(c5639): 1–8.
29. Ringborg A, Berg J, Norman M, Westgren M, Jönsson B. Preterm birth in Sweden: What are the aver-
age lengths of hospital stay and the associated inpatient costs? Acta Paediatr. 2006; 95: 1550–1555.
PMID: 17129960
30. Lawn JE, Blencowe H, Pattinson R, Cousens S, Kumar R, Ibiebele I, et al. Stillbirths: Where?When?
Why? How to make the data count? Lancet. 2011; 377: 1448–1463. doi: 10.1016/S0140-6736(10)
62187-3 PMID: 21496911
VLBW and VLGA Infants in Seven European Countries
PLOS ONE | DOI:10.1371/journal.pone.0131685 June 29, 2015 12 / 12
